The Official Medicare Set Aside Blog And Information Resource

HHS Revises Buprenorphine Prescribing Requirements for Treating Opioid Addiction

Medicare Set-Aside Blog, Rx/Pharmacy on June 1, 2021
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

by Leah King, PharmD, JD, Independent Pharmacy Consultant & Charlotte Chovanec, RN, BSN, MHA, Clinical Director Although we don’t hear as much about it as we once did, the opioid crisis has continued to rage during the COVID-19 pandemic. Originally issued in October 2020, and updated in April 2021, the American Medical Association (AMA) published […] Continue

How Recent Rx Price Increases Will Impact WCMSAs

Medicare Set-Aside Blog, MSAs, Rx/Pharmacy on March 16, 2021
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

So far, 2021 has differed from previous years in many respects, but one thing has held true – drug prices went up. In late December and early January, drug manufacturers increased the price of more than 700 drugs. On average, prices rose by 4.5%.[1] Both of these numbers are consistent with price increases over the […] Continue

COVID-19’s Effect on the Opioid Crisis

Medicare Set-Aside Blog, Opioids, Rx/Pharmacy on December 29, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

For the past several months, you likely haven’t read or seen much about the opioid crisis. All of the information about the opioid crisis that once flooded your inboxes and social media feeds has seemingly been replaced with news related to the COVID-19 pandemic. While it can sometimes be said that no news is good […] Continue

FDA Approves Non-Opioid Analgesic for Mild to Moderate Pain

FDA, Medicare Set-Aside Blog, Rx/Pharmacy on August 3, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

On July 16th, the FDA approved Orphengesic Forte, a non-opioid combination analgesic for the treatment of mild to moderate pain associated with acute musculoskeletal conditions. The FDA’s approval came earlier than expected, which many have viewed as a reinforcement of the FDA’s commitment to do everything in its power to combat the opioid epidemic. Orphengesic […] Continue

The Effectiveness of Ketamine Infusion for Chronic Pain

Medicare Set-Aside Blog, Medicare Set-Asides, Rx/Pharmacy on June 8, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

Patients with chronic pain often present a challenging treatment scenario for health care practitioners. This has historically been the case, and the opioid crisis has served to create additional challenges by discouraging the use of opioids which have traditionally been the mainstays of pain therapy. Because of the opioid epidemic, treatment guidelines have emerged which […] Continue